Get notified when PMI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (new) — Auditor and management both concluded substantial doubt exists about the company's ability to continue operating for twelve months due to recurring losses and insufficient cash runway.
  • Material Weakness (new) — Company disclosed ineffective internal controls with material weaknesses stemming from inadequate accounting personnel and absence of formal multi-level review processes.
NYSE: PMI Picard Medical, Inc. 10-K

Picard Medical posts $27M loss, raises going-concern doubt despite IPO and debt financing

Filed March 30, 2026 · Period ending December 31, 2025 · ~2 min read

Key Changes

  • high

    Auditor raised substantial doubt about PMI's ability to continue operating due to $27M net loss in 2025, $15.7M operating cash burn, and insufficient runway without additional capital. Management states existing cash will NOT fund operations for twelve months.

    MD&A: Going Concern / Notes: Liquidity verify on EDGAR →
  • high

    Two months after $15.2M IPO, PMI raised $15M via senior secured notes with 7M warrants at $2.675 (33% below IPO price). Company may issue up to $35M more notes, signaling ongoing capital needs and significant dilution risk from 7.7M warrants outstanding.

    Business: December 2025 Financing verify on EDGAR →
  • high

    All revenue depends on single FDA-approved product (SynCardia TAH) manufactured by hand at one facility with no backup suppliers for critical components. Loss of trained technicians or supply disruptions could halt production entirely.

    Risk Factors: Manufacturing / Supplier Concentration verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade PMI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify